ERBI unveils new name and brand identity: One Nucleus
One Nucleus is a new name for a new era, representing one network for biotech, pharma, medical device and diagnostic businesses. One Nucleus also speaks to the unification of the Cambridge and London Networks, following ERBI’s merger with the London Biotechnology Network (LBN).
One Nucleus CEO, Harriet Fear, commented: “One Nucleus is the business catalyst for life sciences. We’d outgrown ERBI and needed a new name to match our reality as a global force in life science and healthcare. We intend to use this new identity as a springboard to new and improved benefits for members, building on the combined strength of our Cambridge and London membership.”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.